Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle.
Level 5 - mechanism / opinion, no new human data
Preclinical animal study without human data
PubMed 24797481 · doi:10.1126/science.1251152
What was done
Researchers investigated the effects of restoring circulating growth differentiation factor 11 (GDF11) in aged mice using heterochronic parabiosis and systemic administration of recombinant GDF11 protein. They evaluated muscle stem cell (satellite cell) function, genomic integrity, muscle structural and functional parameters, strength, and endurance exercise capacity.
What was found
The abstract reports no numerical values or effect sizes. Supplementing GDF11 in aged mice reversed functional impairments and restored genomic integrity in muscle satellite cells, while also improving muscle structure, function, strength, and endurance exercise capacity.
Why it matters
This paper identifies GDF11 as a circulating factor capable of reversing aspects of skeletal muscle aging in a rodent model. It points to systemic humoral factors as potential therapeutic targets for age-related muscle dysfunction.
Limits
The study was conducted entirely in mice, so translational relevance and safety in humans remain unproven. The abstract provides no sample sizes, effect sizes, statistical measures, dosing details, or evaluation of potential off-target or adverse effects.
Cited by
- supports Amy Wagers' laboratory found that GDF11 declines with age and that administering GDF11 to older mice replicates the rejuvenating benefits of young blood.